Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. [electronic resource]
Producer: 20040520Description: 4570-7 p. digitalISSN:- 1078-0432
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Boronic Acids -- pharmacology
- Bortezomib
- Caspases -- metabolism
- Complement Membrane Attack Complex
- Complement System Proteins
- Cysteine Endopeptidases -- drug effects
- Cytochromes c -- metabolism
- DNA (Cytosine-5-)-Methyltransferases -- antagonists & inhibitors
- Drug Resistance, Neoplasm
- Enzyme Activation
- Glucocorticoids -- pharmacology
- Glycoproteins -- metabolism
- Humans
- Inhibitor of Apoptosis Proteins
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Lymphocytes -- drug effects
- Mitochondria -- drug effects
- Multienzyme Complexes -- drug effects
- Neoplasm Recurrence, Local -- drug therapy
- Protease Inhibitors -- pharmacology
- Proteasome Endopeptidase Complex
- Proteins -- metabolism
- Pyrazines -- pharmacology
- Tumor Cells, Cultured
- Vidarabine -- analogs & derivatives
- X-Linked Inhibitor of Apoptosis Protein
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.